Lv6
2210 积分 2024-05-01 加入
Safety of non-replicative and oncolytic replication-selective HSV vectors
7天前
已完结
Clinical and translational advances in ovarian cancer therapy
8天前
已完结
HSV-1 as a gene delivery platform for cancer gene therapy
10天前
已完结
Efficient Strategy for Synthesizing Vector-Free and Oncolytic Herpes Simplex Type 1 Viruses
11天前
已完结
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
13天前
已完结
The dynamic role of platelets in cancer progression and their therapeutic implications
21天前
已完结
Phase I Dose-escalation Clinical Trial of HF10 Oncolytic Herpes Virus in 17 Japanese Patients with Advanced Cancer
25天前
已关闭
A Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer
1个月前
已完结
Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma
1个月前
已关闭
Open-Label, Phase II Study of Talimogene Laherparepvec Plus Pembrolizumab for the Treatment of Advanced Melanoma That Progressed on Prior Anti–PD-1 Therapy: MASTERKEY-115,
1个月前
已完结
皖公网安备34019202002308
